Publication | Closed Access

Montmorillonite–chitosan–silver sulfadiazine nanocomposites for topical treatment of chronic skin lesions: In vitro biocompatibility, antibacterial efficacy and gap closure cell motility properties

NanoparticlesEngineeringTopical DrugVitro BiocompatibilityChronic Skin LesionsBiomedical EngineeringDermatologyBiomaterialsBiocompatible MaterialMontmorillonite–chitosan–silver Sulfadiazine Nanocomposites